| Regulatory requirements for food supplements in the European Union and Bulgaria ES Petkova-Gueorguieva, IN Getov, KV Ivanov, SD Ivanova, ... Folia medica 61, 37, 2019 | 14 | 2019 |
| Bulgarian Experience with Adverse Drug Reaction Reports from Patients and Consumers-Retrospective Data-base Study VI Getova, SR Georgiev, AH Stoimenova, ES Petkova-Georgieva Folia Med (Plovdiv) 60 (3), 447-453, 2018 | 10 | 2018 |
| Pharmacists' role in risk communication on self-medication: Pilot study from Bulgaria HV Lebanova, R Staynova, V Getova Drug Safety 41 (11), 1186-1186, 2018 | 4 | 2018 |
| Overview of the legislative framework for pharmaceutical care and its role in the recognition, prevention and management of adverse drug reactions V Getova, A Stoimenova, S Georgiev INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 39 (3), 618-618, 2017 | 2 | 2017 |
| Medicine packaging pictograms in the context of the electronic product information (ePI) proposal V Getova, I Getov European Journal of Hospital Pharmacy, 2021 | 1 | 2021 |
| Safety limitations of fluoroquinolones’ use V Getova, I Getov | 1* | |
| Analysis of marketing authorization procedures with negative opinion 2020-2021–how EMA handled challenges in drug therapy during Covid-19 pandemic V Getova, I Getov Annual for Hospital Pharmacy 7 (1), 13-19, 2021 | | 2021 |
| Awareness of pregnant women about the spontaneous adverse drug reaction reporting system in Bulgaria-a pilot study R Staynova, V Getova, S Stoev PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 153-154, 2021 | | 2021 |
| Negative Opinion Of The EMA–Overview On Marketing Authorization Procedures Concluded With Rejection In 2018-2019 V Getova Annual for Hospital Pharmacy 6 (1), 11-17, 2020 | | 2020 |
| Evaluation of Patients’ Knowledge on the Black Triangle Symbol and Meaning–Bulgarian Perspective V Getova, S Gueorgiev, I Getov Enliven: Pharmacovigilance and Drug Safety 6 (3), 019, 2020 | | 2020 |
| Risk-Minimization Measures in the EU: Review of Two Year Period Safety Referral Procedures V Getova, I Getov | | 2020 |
| Overview of regulation and quality aspects of conducting clinical trials and medicinal product use in real-life practice V Getova Annual for Hospital Pharmacy 5 (1), 51-59, 2019 | | 2019 |
| Chronic Disease Sufferers' Willingness to Participate in Spontaneous Adverse Drug Reaction Reporting System V Getova, E Naseva, H Lebanova, I Getov DRUG SAFETY 41 (11), 1128-1128, 2018 | | 2018 |
| Medicines' Packaging Components as a Risk-Minimization Measure: Focus on Ability to Drive and Use Machines V Getova, H Lebanova, A Stoimenova, S Georgiev PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26, 319-320, 2017 | | 2017 |
| Research and analysis of data on the pharmacovigilance system framework in the European Union V Getova, I Getov Annual for Hospital Pharmacy 2 (1), 14-20, 2017 | | 2017 |
| AD-HOC study of pharma companieswillingness to conduct PASS/PAES studies in Bulgaria V Getova, I Getov, M Dimitrova, P Paparkova Scripta Scientifica Pharmaceutica 3 (2), 7-11, 2016 | | 2016 |
| INFORMATIONAL CAMPAIGNS ABOUT THE IMPACT OF MEDICINAL PRODUCTS ON DRIVING AND CONCENTRATION V Getova, M Dimitrova, I Getov PHARMACIA 63 (2), 18-21, 2016 | | 2016 |
